Literature DB >> 21516515

Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients.

R U Pliquett1, C Klein, T Grünewald, B R Ruf, J Beige.   

Abstract

The risk of cytomegalovirus (CMV) reactivation among hemodialysis (HD) patients is unknown. In 52 HD patients from a single center, CMV serology and quantitative PCR were performed. The detection limit of PCR was 20 copies/ml. Here, PCR ruled out CMV viremia, despite CMV-IgM seropositivity in 15.4% patients.

Entities:  

Mesh：

Year:  2011        PMID： 21516515     DOI： 10.1007/s10096-011-1260-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  15 in total

1.  AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.

Authors:  Kate Buchacz; Rose K Baker; Frank J Palella; Joan S Chmiel; Kenneth A Lichtenstein; Richard M Novak; Kathleen C Wood; John T Brooks
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes.

Authors:  Nicolle H R Litjens; Corné J van Druningen; Michiel G H Betjes
Journal:  Clin Immunol       Date:  2005-10-27       Impact factor: 3.969

3.  CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD.

Authors:  Michiel G H Betjes; Willem Weimar; Nicolle H R Litjens
Journal:  J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 10.121

4.  Naïve and central memory T-cell lymphopenia in end-stage renal disease.

Authors:  J-W Yoon; S Gollapudi; M V Pahl; N D Vaziri
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

5.  Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay.

Authors:  Laurent Kaiser; Luc Perrin; Bernard Chapuis; Karine Hadaya; Lenka Kolarova; Christelle Deffernez; Saadia Huguet; Claudine Helg; Werner Wunderli
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.

Authors:  A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; B Wahren
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Authors:  George C Wang; Wen Hong L Kao; Peter Murakami; Qian-Li Xue; Roger B Chiou; Barbara Detrick; John F McDyer; Richard D Semba; Vincenzo Casolaro; Jeremy D Walston; Linda P Fried
Journal:  Am J Epidemiol       Date:  2010-04-16       Impact factor: 4.897

Review 8.  Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies.

Authors:  Shane D Scott
Journal:  Pharmacotherapy       Date:  2002-09       Impact factor: 4.705

9.  Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients.

Authors:  Nicolle Helena Renier Litjens; Martin Huisman; Marinus van den Dorpel; Michiel Gerardus Henricus Betjes
Journal:  J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 10.121

10.  The impact of cytomegalovirus infection ≥1 year after primary renal transplantation.

Authors:  Barry J Browne; Jo-Anne Young; Ty B Dunn; Arthur J Matas
Journal:  Clin Transplant       Date:  2010 Jul-Aug       Impact factor: 2.863
View more
  2 in total

1.  Human cytomegalovirus inhibits erythropoietin production.

Authors:  Lynn M Butler; Mensur Dzabic; Frank Bakker; Belghis Davoudi; Hannah Jeffery; Piotr Religa; Krzysztof Bojakowski; Koon-Chu Yaiw; Afsar Rahbar; Cecilia Söderberg-Naucler
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 2.  Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.

Authors:  Jan Styczynski
Journal:  Infect Dis Ther       Date:  2017-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.